Gerard M Walls
Overview
Explore the profile of Gerard M Walls including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
102
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Walls G, Pellini B, Chaudhuri A
J Liq Biopsy
. 2025 Mar;
6:100160.
PMID: 40027308
Locally advanced non-small cell lung cancer (NSCLC) is a highly diverse disease in terms of its histology, staging and molecular biology, yet chemoradiation treatment paradigms are currently not individualized for...
2.
Walls G, Bergom C, Mitchell J, Rentschler S, Hugo G, Samson P, et al.
Br J Cancer
. 2025 Jan;
132(4):401-407.
PMID: 39775164
No abstract available.
3.
Hill N, Hanna G, Walls G, McAleese J
JTO Clin Res Rep
. 2024 Dec;
5(12):100739.
PMID: 39735887
No abstract available.
4.
Walls G, Van Herk M, Faivre-Finn C
Lancet Respir Med
. 2024 Dec;
12(12):e75.
PMID: 39638533
No abstract available.
5.
Walls G, Bergom C, Mitchell J, Rentschler S, Hugo G, Samson P, et al.
Br J Cancer
. 2024 Nov;
132(4):311-325.
PMID: 39506136
Radiotherapy is the standard of care treatment for unresectable NSCLC, combined with concurrent chemotherapy and adjuvant immunotherapy. Despite technological advances in radiotherapy planning and delivery, the risk of damage to...
6.
Walls G, Hill N, McMahon M, Kearney B, McCann C, McKavanagh P, et al.
JACC CardioOncol
. 2024 Sep;
6(4):529-540.
PMID: 39239328
Background: Radiation-induced cardiotoxicity poses a significant challenge in lung cancer management because of the close anatomical proximity of the heart to the lungs, compounded by a high prevalence of cardiovascular...
7.
Walls G, Mistry H, Barlesi F, Bezjak A, Le Pechoux C, OBrien M, et al.
Int J Radiat Oncol Biol Phys
. 2024 Mar;
119(5):1386-1390.
PMID: 38521132
Purpose: CONVERT was a phase 3 international randomized clinical trial comparing once-daily (OD) and twice-daily (BD) radiation therapy (RT). This updated analysis describes the 6.5-year outcomes of these regimens delivered...
8.
Walls G, Bergom C
Int J Radiat Oncol Biol Phys
. 2024 Feb;
118(4):1078-1080.
PMID: 38401968
No abstract available.
9.
Ghita-Pettigrew M, Edgar K, Kuburas R, Brown K, Walls G, Facchi C, et al.
Radiother Oncol
. 2024 Feb;
193:110113.
PMID: 38301958
Background And Purpose: Radiation induced cardiotoxicity (RICT) is as an important sequela of radiotherapy to the thorax for patients. In this study, we aim to investigate the dose and fractionation...
10.
Brown K, Ghita-Pettigrew M, Kerr B, Mohamed-Smith L, Walls G, McGarry C, et al.
Radiother Oncol
. 2024 Jan;
192:110106.
PMID: 38253201
Background And Purpose: Radiomics is a rapidly evolving area of research that uses medical images to develop prognostic and predictive imaging biomarkers. In this study, we aimed to identify radiomics...